Healthy Aging Starts at the Cellular Level

Laponicum isolates bioactive compounds from Arctic plants that support cellular recycling, signaling and modulation— addressing the biological drivers of age-related decline and promoting long-term gut, kidney and eye health.
Contact us

Laponicum’s mission is to provide healthspan solutions through Arctic polyphenols.

Living longer does not necessarily mean living better.

As populations age worldwide, age-related health decline has become one of the greatest challenges facing healthcare systems and society.

Many conditions stem from gradual deterioration of the cellular processes responsible for maintenance, communication and repair.

Supporting Nordic scientists and utilizing the unique biodiversity of Arctic plants, Laponicum’s identifies and develops bioactive polyphenols that support cellular recycling, signaling and biological modulation.

By targeting root mechanisms age-related health conditions, we aim to help preserve healthy function in the gut, kidneys and eyes throughout life.

Gut Health

Gastrointestinal Disorder affects over 35% of the adult population.

Laponicum is developing proanthocyanidin solutions that modify the gut microbiome, strengthen mucosal immunity and improve gut wall function in aging populations.

Kidney and urinary health

Chronic Kidney Desease is linked to age degradation of tissues. Urinary Tract Infection is the leading cause of bacterial infection in post-menopausal women.

Laponicum is developing phenolic compounds to protect the Kidney and modify the urinary microbiome in a novel nutraceutical approach to improved health outcomes in female populations.

Macular degeneration

200 million people are facing blindness due to Age-Related Macular Degeneration.

Laponicum is developing a phenolic solution to stimulate the autophagy response in retinal cells in a potentially groundbreaking approach to age-related blindness.

Arctic plants adapt to extreme environmental conditions,
resulting in unique and highly concentrated profiles of bioactive compounds.

Arctic plant polyphenols improve healthspan

Our platform leverages the unique phytochemical profiles of Arctic plants to create highly concentrated ingredients rich in proanthocyanidins and other bioactive polyphenols. These natural compounds support health through modes of action such as microbiome modulation and cellular signaling.

How it works

• Microbiome modulation
• Gut barrier function
• Gut immunity function
• Inflammatory signalling

What's in it?

• Polyphenols
• Anthocyanins
• Proanthocyanidins
• Unique plant bioactives

Why Arctic?

• Extreme climate stress
• Protective plant biology
• Distinct botanic profiles
• Traditional use heritage

How it is measured

• Inflammation biomarkers
• Agglutination assays
• Vascular function markers
• Improved gut comfort

Science partners

In partnership with leading research institutions, we are developing novel nutraceutical solutions that promote longevity, cellular resilience, and healthy aging. There are active projects involving microbiome modulation seeking to improve healthcare outcomes in gut health, renal, urinary, inflammatory and metabolic need states.
Laponicum’s Science Advisory Board guides our progress and helps allocate focus between projects and priorities.
Nordic life scientists are experts in advanced biological research on the role of plant bioactives in humans for preventive health, healthy aging, and nutrition. We work with Nordic scientists in pioneering new approaches aimed at supporting cellular health, resilience, and the prevention of age-related disease.

Business segments

Laponicum AS operates in two different markets, using two different tradenames.

PhenoNordia™ is a trademark launched and currently marketing ingredient solutions for dietary supplements.

InnoNordia™ is targeting medical food with a pipeline of applications in gut, renal and eye health.

The two units comply with two very different regulatory and competitive landscapes across multiple need state solutions.

Nutraceutical

Launched

Go to website
Medical Food

Under development

About us

Laponicum AS is a Norwegian nutraceutical platform company combining proprietary polyphenol extraction technology, sustainable Arctic raw materials, and a science-driven approach to healthy aging.

Founded in 2025, the company is building a portfolio of high-value ingredients targeting large and growing healthspan markets.

Through its PhenoNordia business unit, Laponicum is generating near-term revenues with premium, excipient-free formulations.

This commercial foundation supports the development of proprietary, science-backed health solutions with the potential to transform nutraceutical and medical food categories.

Stein Ulve

Founder & CEO
B
E

Read bio

As Co-Founder and CEO of Laponicum, Stein Ulve provides the strategic vision driving the company's Arctic healthspan platform.

He has over 30 years’ experience building ingredient businesses, developing international partnerships, and bringing science-driven innovations to market.

Stein leads Laponicum's mission to establish a globally recognized platform for Arctic polyphenols and related natural health solutions.

Erik Eide

Commercial Director
B
E
Read bio
Erik Eide is a seasoned executive with over 25 years’ international experience building high-growth nutraceutical businesses.

As Co-Founder and Commercial Director, Erik leads Laponicum’s commercialization and growth initiatives, connecting the company's pioneering Arctic polyphenol platform with global customers, industry partners, and investors.

His expertise spans product innovation, new category development, strategic partnerships, and scaling science-backed nutraceutical businesses.

Karl-Johan Jakola

Board Member
B
E
Read bio
Karl-Johan Jakola is a highly respected entrepreneur, investor, and venture capital professional with extensive experience in building and financing research-based businesses.

Through his work with Norinnova's investment and commercialization platforms, he has helped launch and grow numerous Nordic technology and life science companies.

He brings deep expertise in corporate strategy, investment, and business development to Laponicum's Board.

Terry Virts

Board Member
B
E
Read bio
Terry Virts is a former NASA astronaut and Commander of the International Space Station, with extensive experience in aerospace, entrepreneurship, and corporate governance.

Renowned for his leadership, strategic vision, and ability to execute at scale, he brings valuable expertise in building high-impact organizations, fostering international collaboration, and turning ambitious ideas into globally relevant ventures.

His perspective supports Laponicum’s mission to transform Arctic science into world-class health innovations.

Thomas Helge Hansen

Board Member
B
E
Read bio
Thomas Helge Hansen has over two decades of nutraceutical leadership experience in the global omega-3 and dietary supplement industry with focus on developing new commercial partnerships and growth strategies for emerging science-based health ingredients.

Thomas brings broad expertise in international business development, supplement manufacturing, sourcing, and commercialization, supporting Laponicum's ambition to build a leading, vertically integrated platform for Arctic health innovations.
Laponicum logo

Start a conversation

Laponicum welcomes conversations with investors, strategic partners and research collaborators interested in preventive health, Arctic polyphenols, healthspan and next-generation health ingredients.

Our location

PhenoNordia

Contact us to discuss your inquiry or explore potential opportunities. Use the form below, or reach us directly at info@laponicum.com.

Contact form

All fields marked with * are required. We aim to respond within two business days.
Consent / privacy checkbox
I agree that Laponicum may contact me regarding my inquiry.